Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy

NCT00396721 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Glomerulonephritis, IGA
Nephropathy, IGA
IGA Nephropathy

Interventions

DRUG: ACE inhibitor + statin
DRUG: Sirolimus (study drug)+ACE inhibitor + statin

Sponsor

Josep m Cruzado

Collaborators

[object Object]